Literature DB >> 10534355

Clinical features of hepatitis C-infected patients with persistently normal alanine transaminase levels in the Southwestern United States.

M M Jamal1, A Soni, P G Quinn, D E Wheeler, S Arora, D E Johnston.   

Abstract

Approximately one third of patients with chronic hepatitis C virus (HCV) infection have normal alanine transaminase (ALT) levels. We studied the clinical, biochemical, virological, and histological features in patients with persistently normal ALT. A case-control study was conducted on 275 patients with chronic HCV infection, including 75 patients with persistently normal ALT and 200 patients with abnormal ALT. Persistently normal ALT was defined as 4 consecutive ALT values in each patient within a period of 12 months. The average age of the patients was 44 years (range 18 to 69 years). More non-Hispanic whites had persistently normal ALT. The mean serum ferritin level was significantly lower in patients with persistently normal ALT as compared with abnormal ALT (128 +/- 92 ng/mL and 224 +/- 128 ng/mL), respectively (P =.017). The mean HCV-RNA level was significantly lower in patients with persistently normal ALT as compared with abnormal ALT (12 x 10(5) +/- 2.8 x 10(6) copies/mL and 33 x 10(5) +/- 8.0 x 10(6)), respectively (P =.02). Histologically, patients with persistently normal ALT had less severe portal inflammation (P <.05), lobular inflammation (P =.003), piecemeal necrosis (P =.002), fibrosis (P <.05), lower prevalence of cirrhosis (P =.007), as well as a slower fibrosis progression rate (P <.001). Chronic hepatitis C patients with persistently normal ALT have low-activity grade and stage on liver biopsy. In these patients the hepatitis C RNA level was lower compared with abnormal ALT patients, which may explain the slower fibrosis progression rate.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10534355     DOI: 10.1002/hep.510300526

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  17 in total

1.  Increased hepatitis C virus (HCV)-specific CD4+CD25+ regulatory T lymphocytes and reduced HCV-specific CD4+ T cell response in HCV-infected patients with normal versus abnormal alanine aminotransferase levels.

Authors:  F Bolacchi; A Sinistro; C Ciaprini; F Demin; M Capozzi; F C Carducci; C M J Drapeau; G Rocchi; A Bergamini
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

2.  Intrahepatic and peripheral T-cell responses in genotype 1b hepatitis C virus-infected patients with persistently normal and elevated aminotransferase levels.

Authors:  Filiz Akyüz; Nuray Polat; Sabahattin Kaymakoglu; Nevzat Aksoy; Kadir Demir; Fatih Beşişik; Selim Badur; Yilmaz Cakaloglu; Atilla Okten
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

3.  Predictors and effects of alcohol use on liver function among young HCV-infected injection drug users in a behavioral intervention.

Authors:  Lydia N Drumright; Holly Hagan; David L Thomas; Mary H Latka; Elizabeth T Golub; Richard S Garfein; John D Clapp; Jennifer V Campbell; Sebastian Bonner; Farzana Kapadia; Thelma King Thiel; Steffanie A Strathdee
Journal:  J Hepatol       Date:  2010-11-24       Impact factor: 25.083

Review 4.  Should patients with chronic hepatitis C who have normal ALT levels be treated?

Authors:  M W Russo; R S Brown
Journal:  Curr Gastroenterol Rep       Date:  2001-02

5.  Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levels.

Authors:  C Renou; P Halfon; S Pol; P Cacoub; E Jouve; J P Bronowicki; J P Arpurt; H Rifflet; M Picon; X Causse; V Canva; J Denis; A Tran; M Bourliére; D Ouzan; A Pariente; S Dantin; L Alric; V Cartier; M Reville; S Caillat-Zucman
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

6.  The management of chronic viral hepatitis: A Canadian consensus conference 2004.

Authors:  Morris Sherman; Vincent Bain; Jean-Pierre Villeneuve; Robert P Myers; Curtis Cooper; Steven Martin; Catherine Lowe
Journal:  Can J Infect Dis Med Microbiol       Date:  2004-11       Impact factor: 2.471

Review 7.  [Liver biopsy at the intersection of clinical and pathological diagnosis].

Authors:  U Spengler; H-P Fischer
Journal:  Pathologe       Date:  2008-02       Impact factor: 1.011

8.  Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study.

Authors:  Hyeon Chang Kim; Chung Mo Nam; Sun Ha Jee; Kwang Hyub Han; Dae Kyu Oh; Il Suh
Journal:  BMJ       Date:  2004-03-17

9.  Clinical features of hepatitis C virus carriers with persistently normal alanine aminotransferase levels.

Authors:  Hirofumi Uto; Seiich Mawatari; Kotaro Kumagai; Akio Ido; Hirohito Tsubouchi
Journal:  Hepat Mon       Date:  2012-02-29       Impact factor: 0.660

10.  Sage tea drinking improves lipid profile and antioxidant defences in humans.

Authors:  Carla M Sá; Alice A Ramos; Marisa F Azevedo; Cristovao F Lima; Manuel Fernandes-Ferreira; Cristina Pereira-Wilson
Journal:  Int J Mol Sci       Date:  2009-09-09       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.